| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-12 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-08 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |